StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
10
Publishing Date
2023 - 11 - 25
1
2023 - 08 - 30
1
2022 - 08 - 29
1
2022 - 07 - 21
1
2022 - 07 - 13
1
2022 - 06 - 22
1
2022 - 06 - 20
1
2022 - 03 - 22
1
2022 - 03 - 01
1
2021 - 10 - 20
1
Sector
Commercial services
1
Communications
1
Health technology
10
Manufacturing
2
Process industries
1
Tags
Agreement
8
Alzheimer's
10
America
67
Antibody
8
Application
8
Approval
13
Biosimilar
32
Breast
13
Business
9
Cancer
91
Cell
9
Chmp
10
Diabetes
15
Diagnostics
17
Disease
61
Drug
85
Earnings
18
Europe
15
Expansion
10
Expected
35
Eye
15
Fda
22
Financial
24
Global
228
Growing
43
Growth
235
Health
19
Immunotherapy
11
Infection
9
Kisqali
11
Leukemia
10
Liver
11
Market
592
N/a
945
Novartis
132
People
13
Pharma
13
Pharmaceuticals
17
Pipeline
12
Positive
15
Potential
10
Reach
34
Report
194
Research
118
Respiratory
11
Results
38
Risk
10
Sales
9
Sclerosis
13
Set
15
Study
15
T-cell
11
Technology
12
Therapeutics
109
Therapy
64
Treatment
113
Trial
16
Update
10
Vaccine
10
Year
12
Entities
Abbott laboratories
2
Altimmune, inc.
1
Arrival
2
Astrazeneca plc
4
Elanco animal health incorporated
1
Glaxosmithkline plc
6
Inovio pharmaceuticals, inc.
1
Johnson & johnson
5
Novartis ag
10
Orange
1
Sanofi
10
Xenetic biosciences, inc.
1
Zoetis inc.
1
Symbols
ABT
10
ACIU
10
AGEN
13
ALPMF
7
ALPMY
7
AMRS
8
ANIX
24
APDN
9
ARCT
18
ARVL
31
AZN
29
AZNCF
19
BNTX
111
BWV
20
CMXHF
7
CNC
8
CSLLY
7
CVAC
25
CVS
12
DVAX
82
DYAI
17
EBS
15
EVAX
17
FNCTF
34
GLAXF
35
GOVX
32
GRTS
23
GSK
56
IBRX
10
ICVX
7
INO
22
JNJ
327
LLY
8
MRK
20
MRNA
142
NRXP
11
NVAX
132
NVS
16
NVSEF
10
OCGN
25
ORMP
11
PAHC
9
PCVX
10
PDSB
9
PFE
106
SNGX
12
SNY
258
SNYNF
163
SRNE
8
STRO
9
TAK
27
TMO
8
TNXP
26
TSN
8
VAXX
9
VBIV
64
VCNX
34
VIR
9
VXRT
44
ZTS
9
Exchanges
Nasdaq
10
Nyse
10
Crawled Date
2023 - 11 - 25
1
2023 - 08 - 30
1
2022 - 08 - 29
1
2022 - 07 - 21
1
2022 - 07 - 13
1
2022 - 06 - 22
1
2022 - 06 - 20
1
2022 - 03 - 22
1
2022 - 03 - 01
1
2021 - 10 - 20
1
Crawled Time
01:00
1
08:20
1
12:00
1
13:00
1
18:00
3
19:00
3
Source
www.prnewswire.com
10
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Vaccine
symbols :
Nvsef
save search
Rabies Vaccine Market to Reach $ 1903.17 million by 2032, exhibiting a CAGR of 4.7% from 2023 to 2032: Allied Market Research
Published:
2023-11-25
(Crawled : 08:20)
- prnewswire.com
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
ELAN
|
$13.41
-1.69%
-0.45%
4.1M
|
Process Industries
|
Email alert
Add to watchlist
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
ZTS
|
$151.94
-0.71%
2.38%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
FNCTF
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
vaccine
reach
research
market
Empowering Healthcare: Global Vaccine Management System Market to Reach $441.17 million by 2028
Published:
2023-08-30
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
11.79%
|
O:
-1.57%
H:
0.0%
C:
0.0%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
-2.73%
|
O:
0.56%
H:
0.0%
C:
-2.26%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-10.13%
|
O:
-0.25%
H:
0.47%
C:
-1.08%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-12.28%
|
O:
0.56%
H:
0.0%
C:
0.0%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
12.5%
|
O:
0.54%
H:
0.27%
C:
-0.59%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-15.05%
|
O:
0.66%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
-1.27%
|
O:
0.46%
H:
0.17%
C:
-0.86%
management
vaccine
reach
global
system
market
Vaccines Global Market Set to Surpass $163.8 Billion by 2026
Published:
2022-08-29
(Crawled : 12:00)
- prnewswire.com
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
12.26%
|
O:
0.39%
H:
0.05%
C:
-0.9%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-13.74%
|
O:
-2.43%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
10.5%
|
O:
-1.08%
H:
0.0%
C:
0.0%
global
set
market
vaccine
Human Papillomavirus Vaccine (HPV) Market to Reach $10.8 Bn, Globally, by 2031 at 12.4% CAGR: Allied Market Research
Published:
2022-07-21
(Crawled : 13:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-1.32%
|
O:
6.64%
H:
0.0%
C:
-4.08%
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-12.14%
|
O:
-2.38%
H:
0.0%
C:
0.0%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
4.15%
|
O:
0.15%
H:
0.0%
C:
-3.5%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
10.21%
|
O:
0.09%
H:
1.9%
C:
1.89%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-16.11%
|
O:
-1.18%
H:
0.0%
C:
0.0%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
-3.97%
|
O:
1.3%
H:
0.38%
C:
-0.38%
XBIO
|
$4.015
-4.09%
2.8K
|
Health Technology
|
-95.17%
|
O:
0.41%
H:
7.44%
C:
-2.71%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-9.86%
|
O:
-3.38%
H:
0.0%
C:
0.0%
INO
|
$11.05
14.69%
12.81%
700K
|
Health Technology
|
332.06%
|
O:
0.0%
H:
1.35%
C:
-5.83%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
3.76%
|
O:
-2.75%
H:
2.31%
C:
2.15%
research
vaccine
market
Insights on the Influenza Vaccine Global Market to 2027 - by Vaccine Type, Technology, Age Group, Route of Administration and Region
Published:
2022-07-13
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-20.39%
|
O:
-3.79%
H:
2.41%
C:
0.26%
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-7.1%
|
O:
-1.46%
H:
0.09%
C:
0.09%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
4.1%
|
O:
-2.09%
H:
1.62%
C:
1.62%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
35.22%
|
O:
-1.35%
H:
0.4%
C:
0.27%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
11.82%
|
O:
-1.04%
H:
0.62%
C:
0.55%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
-21.9%
|
O:
-1.96%
H:
0.35%
C:
0.25%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
2.82%
|
O:
-1.49%
H:
1.23%
C:
1.03%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-7.37%
|
O:
-1.27%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
2.96%
|
O:
-2.73%
H:
0.95%
C:
0.91%
vaccine
influenza
market
Global Recombinant Vaccines Market to Surpass US$ 1,809.7 Million by 2030 - Coherent Market Insights
Published:
2022-06-22
(Crawled : 18:00)
- prnewswire.com
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
12.32%
|
O:
-1.57%
H:
0.0%
C:
0.0%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-14.9%
|
O:
1.36%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-8.15%
|
O:
-0.4%
H:
0.0%
C:
0.0%
market
vaccine
Global Meningitis Vaccines Market to Surpass US$ 6,669.3 Million by 2030 - Coherent Market Insights
Published:
2022-06-20
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-21.65%
|
O:
1.07%
H:
4.05%
C:
-0.53%
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-8.52%
|
O:
-3.92%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
42.5%
|
O:
4.65%
H:
0.0%
C:
-4.51%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
13.9%
|
O:
1.41%
H:
0.0%
C:
0.0%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
-3.48%
|
O:
26.81%
H:
0.14%
C:
-0.52%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-6.86%
|
O:
1.4%
H:
0.0%
C:
0.0%
market
vaccine
Outlook on the Travel Vaccines Global Market to 2028 - Increasing Travel and Tourism is Driving Growth
Published:
2022-03-22
(Crawled : 18:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-9.05%
|
O:
0.9%
H:
0.0%
C:
-8.17%
ARVL
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-84.93%
|
O:
-0.55%
H:
0.0%
C:
0.0%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
7.1%
|
O:
-0.93%
H:
0.0%
C:
0.0%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
-7.33%
|
O:
0.79%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-11.12%
|
O:
0.15%
H:
0.0%
C:
0.0%
travel
growth
vaccine
Insights on the Travel Vaccines Global Market to 2027 - by Composition, Disease and Region
Published:
2022-03-01
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-12.93%
|
O:
-1.09%
H:
0.05%
C:
0.05%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
10.91%
|
O:
0.37%
H:
2.02%
C:
2.02%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
8.13%
|
O:
1.39%
H:
0.0%
C:
0.0%
ARVL
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-83.82%
|
O:
5.88%
H:
0.0%
C:
0.0%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
5.31%
|
O:
-1.55%
H:
0.0%
C:
0.0%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-11.6%
|
O:
0.64%
H:
0.0%
C:
0.0%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-9.17%
|
O:
-1.34%
H:
2.05%
C:
1.47%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-10.79%
|
O:
-1.96%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
9.64%
|
O:
-0.62%
H:
0.0%
C:
0.0%
ALT
|
$7.05
-6.25%
-6.67%
3.6M
|
Commercial Services
|
3.16%
|
O:
2.74%
H:
1.34%
C:
-2.14%
travel
disease
vaccine
Outlook on the Meningococcal Vaccines Global Market to 2026 - Focus on Conjugate, Polysaccharide and Subcapsular Vaccine Types
Published:
2021-10-20
(Crawled : 18:00)
- prnewswire.com
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
11.63%
|
O:
1.2%
H:
0.96%
C:
0.38%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
1.99%
|
O:
0.2%
H:
0.75%
C:
0.54%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.56%
|
O:
2.37%
H:
0.65%
C:
-0.3%
vaccine
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.